PLPL Entering Medical Marijuana Plandai

New Post Public Reply Private Reply Replies (0) Message Board

Nov 1, 2013 at 9:06 AM

*****PLPL Entering Medical Marijuana ***** Plandai Biotechnology, Inc. to Enter Medical Marijuana Field With Phyto Cannabinoid Extract Announces Formation of Cannabis Biosciences, Inc. to Develop Pharmaceutical Applications SEATTLE, WA--(Marketwired - Oct 30, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that it has formed a new wholly-owned subsidiary, Cannabis Biosciences, Inc., in Delaware, for the purpose of developing and testing a new Phytofare™ botanical extract derived from cannabis. Preliminarily dubbed Phytofare™ Phyto-cannabinoid Complex, the new extract will share a similar extraction process to the other Phytofare™ products and is expected to demonstrate the same high levels of bioavailability and purity. During the extraction process the company could also remove the psychoactive compound (THC), rendering a botanical drug that offers many of the medicinal benefits of cannabis without the perceived negative side effects and social stigma. Cannabis has shown strong medicinal potential across multiple fields in numerous independent clinical trials, including controlling symptoms of ALS (Lou Gehrig's Disease), Multiple Sclerosis and Crohn's disease, managing insulin levels in diabetics, and fighting breast cancer. THC has also been shown to help in reducing brain tumors and slowing the advance of Alzheimer's. In fact, the United States Department of Health and Human Services states in a 2001 U.S. Patent Application (Patent Number 6,630,507) that: "Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention." Roger Duffield, Chairman and Chief Executive Officer of Plandaí Biotechnology, commented, "For the past twelve months, the Plandaí team has been working with cannabis to first ascertain if our patent-pending process could produce a phyto-cannabinoid extract that exhibits the same high bioavailability of our other Phytofare™ products. Working with cannabis presents unique challenges in that it produces a very sticky oil that must be dealt with -- and that only after navigating the complex legal obstacles. However, the medicinal opportunities associated with phyto-cannabinoids are simply too great to ignore." Mr. Duffield indicated that, having completed the science, preliminary bioavailability testing should commence in early 2014 with clinical trials commencing later in the year to pursue various pharmaceutical and nutraceutical applications. About Plandaí Biotechnology, Inc. Plandaí Biotechnology, Inc. and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its patented Phytofare™ extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com. Safe Harbor Statement The information provided may contain forward-looking statements and involve risks and uncertainties. Results, events and performances could vary from those contemplated. These statements involve risks and uncertainties which may cause actual results, expressed or implied, to differ from predicted outcomes. Risks and uncertainties include product demand, market competition, and Plandaí's ability to meet current or future plans. Investors should study and understand all risks before making an investment decision. Readers are recommended not to place undue reliance on forward-looking statements or information. Plandaí is not obliged to publicly release revisions to any forward-looking statement, to reflect events or circumstances afterward, or to disclose unanticipated occurrences, except as required under applicable laws. Contact: Andrew Beyer Phone: 619-202-7456 Email: investor@Plandaíbiotech.com Disclaimer: http://alturl.com/3yt3r

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Indico Breach May Expose Thousands to Identity Theft

Data Breach Unsettles Indico's Operations Well, this is the kind of headache nobody wants on their spreadsheet—the unpleasant fallout from a significant data breach is rocking Indico Data Solutions. When you hear words like 'unauthorized party' and 'exposed sensitive personal information,' it ought to make investors sit up and pay attention. On May 7, 2026, Indico, the...

Palmer's Design Fuels Child Cancer Awareness Drive

Imagine a cancer struggle fueling creativity – a hopeful story from the racetrack lights up this reality as Valvoline and a young survivor rev up their engines for children with blood cancer. Powerful Partnership Takes Unforgettable Turn Palmer Goforth, a twelve-year-old cancer survivor, never imagined his hobby of drawing sketches would lead to designing a NASCAR car....

RELISH 2026: Orange County's Ultimate Food & Drink Bash

A Festival Like No Other If there’s anything Orange County knows how to do, it’s throw a party. And here comes RELISH, a three-day feast for the senses that’ll have foodies talking for weeks. Organized by Celebrity Chef Jamie Gwen and Event Planner Nicole Hirsty, this is not your average town fair. This is indulgence on a silver platter, set to take place from...

Space Collaboration Inches Forward with Extended Talks

It seems like every time you blink, the folks over at Maritime Launch Services and Isar Aerospace are at it again. This time, they've decided to extend the deadline for their statement of work by a couple of weeks—now shooting for mid-September 2026. You could say they're taking their time, but really, sometimes that's what you've gotta do when you're trying to launch...

Salute's T5 Acquisition: A Big Leap in AI/Data Centers

Salute's Bold Strategic Acquisition The only constant in the ever-evolving data center industry is change, and Salute has made a significant leap by acquiring T5 Operations. This move fortifies Salute's standing as a leading global service provider for AI, HPC, and cloud infrastructure. By integrating T5's first-rate expertise with their own, Salute isn't just playing the...

Hormel Foods Gears Up for Barclays Conference

Hormel Foods Takes the Stage at Barclays When it comes to branded food, few players can command attention quite like Hormel Foods Corporation. They're set to make a splash at the upcoming 2026 Barclays Global Consumer Staples Conference. On September 9, Jeff Ettinger, interim CEO, and John Ghingo, the CEO-elect, will lead a fireside chat at 1:30 p.m. ET. They're not just...

Bio-Techne Advances with Science Based Targets in 2026

Greenhouse Gas Reduction: A Bright Spot for Bio-Techne Out of the blue, Bio-Techne is turning heads in the sustainability arena. This ain't just another company going through the greenwashing motion; their fiscal 2026 reports underline genuine strides to axe emissions. Celebrated as NASDAQ: TECH to market insiders, Bio-Techne's journey isn't just about profits but carving...

Teamsters Strike Hits Amazon's Largest U.S. Warehouse

Unrest Brewing in Riverside: Amazon's Labor Showdown September 1, 2026, marks a potentially seismic shift in labor disputes within one of America's corporate titans—Amazon. Picture this: workers slinging on their boots, not for a day of hauling goods in Amazon's largest U.S. warehouse, DJT6, but for a united stand outside its gates. Who's at the helm? The Teamsters...

Adecoagro Expands with Caarapó Mill Acquisition

Crushing the Competition: Adecoagro's New Acquisition When there's dirt under your fingernails and deals in the air, taking a strategic swing like Adecoagro just did can be a game-changer. Shelling out R$705 million (roughly US$136 million) in cash isn't what you'd call pocket change, but they're not new to ballsy moves. They've snapped up the Caarapó Mill, previously...

SCO Agenda: Development, Security, and Global Equity

China's Vision for a Balanced World In a world chock-full of friction and uncertainty, President Xi's proclamation at the recent SCO meeting has struck a chord. The SCO, once a fledgling idea among nations, now stands on the global stage with Xi's ringing call for it to prioritize development and equity in governance. A Subtle Shift in the Global South's Influence Xi's...